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Genomics is the study of the entire human genome and
involves not only studying the actions of single genes but
also the interactions of multiple genes with each other and
with the environment. This article emphasizes the multi-
factorial nature of common obesity, which is caused by the
interaction of genes, environment, and lifestyle. Individual
variation in genes that influence behavior, satiety, and
taste suggests that a one-size-fits-all approach to reducing
or preventing obesity may be ineffective. Data are not yet
available to allow for personalized obesity interventions
based on genetic predisposition. However, a genomics
approach may provide a useful framework for addressing
the obesity epidemic. More research is needed before spe-
cific targeted public health interventions that include
genomic strategies can be effectively integrated into
addressing obesity in public health practice.
Introduction
Obesity is a multifactorial disorder that reflects complex
interactions of genes, environment, and lifestyle.
Considering the obesity epidemic from a genomics per-
spective, which takes into account the effect of all genes in
the genome as well as the interactions of those genes with
each other and with the environment, has the potential to
improve the effectiveness of obesity prevention and inter-
vention strategies.
Evidence of Genetic Role in Weight
Regulation
Numerous family studies indicate a genetic component to
weight regulation. Stunkard et al (1) show that body mass
index (BMI) is highly correlated in identical twins, even if
each twin is raised in a different environment. Studies of
eating behavior in fraternal and identical twin pairs sug-
gest that a significant portion (45%–60%) of eating behav-
iors (e.g., binge eating) was due to genetic factors (2).
Studies of children and their parents also point to a
genetic role for obesity. Whitaker et al (3) reported
that, although not all obese children have obese par-
ents, parental obesity is a significant predictor of chil-
dren’s obesity. Parental obesity more than doubled the
risk of obesity for children younger than 10 years. One
prospective longitudinal study (4) found that the
strongest predictor of obesity was parental obesity,
independent of diet or activity. Another study (5) found
that, after controlling for environmental factors, chil-
dren of obese parents had a higher preference for fatty
foods, a lower liking for vegetables, a greater tendency
to overeat, and a stronger preference for sedentary
activities than did children of normal-weight parents.
How Much of Obesity is Genetic?
Separating genetic factors from other factors is difficult
because genes are part of a dynamic system that is con-
stantly in flux in response to environmental cues.
Nonetheless, some researchers tried to pinpoint the pro-
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portion of obesity attributable to genetic factors as opposed
to environmental factors (e.g., sidewalks, community
design) or lifestyle factors (e.g., diet, physical activity).
Loos et al (6) reviewed genetic epidemiology studies and
concluded that the heritability (proportion of a trait due to
genetic factors but not necessarily single genes) of human
adiposity is between 30% and 70%, with the highest heri-
tability estimates coming from studies of twins. The risk of
obesity (>90th BMI percentile) is two to three times higher
for a person with a family history of obesity than for a per-
son without such history. This risk increases as severity of
family obesity increases. Risk of extreme obesity (BMI >45)
is seven to eight times higher for members of extremely
obese families than for members of normal-weight families.
On the basis of their review, Loos et al suggest four lev-
els of genetic contribution to obesity, two of which are
affected by whether one lives in an obesigenic environment
(i.e., an environment that promotes high caloric intake and
low physical activity). The four levels are 1) genetic obesi-
ty — genetic mutation in a single gene leads to obesity
despite environment (1%–5% of cases); 2) strong predispo-
sition — overweight in nonobesigenic environment and
obese in obesigenic environment; 3) slight predisposition
— normal weight in nonobesigenic environment and over-
weight in obesigenic environment; and 4) genetically
resistant — normal weight in obesigenic environment.
Specific Genes Associated With Obesity
Although a family history of obesity is a strong predictor
of the condition, only 1% to 5% of obesity cases can be
explained by a single gene mutation (6). Common obesity
(which affects most obese people) is a complex disorder
with contributions from multiple genes and gene variants.
However, the search for specific genes associated with obe-
sity provides a foundation for understanding the effect of
environmental and lifestyle factors on the development of
obesity. Mounting evidence suggests that genetic factors
are involved in all aspects of weight regulation, including
food intake and energy expenditure. Hunger or appetite,
eating behavior (e.g., binge eating), taste, satiety, sponta-
neous physical activity (e.g., fidgeting), metabolic rate,
thermogenesis, and motivation to exercise all appear to
have genetic correlates. Most single-gene disorders identi-
fied to date are associated with mutations in genes that
regulate appetite (7).
The list of genes with a possible role in weight regulation
is large; more than 400 genes or markers are associated
with obesity (8). Some of the more commonly discussed
genes and their characteristics are listed in the Table.
Interactions
Some genetic research gives us a glimpse of the complex
relationships between gene variants, genes and age, and
genes and environment.
Gene–gene interactions
Ochoa et al (11) found a significant interaction between
two gene variants, PPAR λ 2 and ADR β 3, in the risk of
obesity in children and adolescents. After adjusting for
family history of obesity, the researchers found that carri-
ers of both gene variants were almost 20 times more likely
to be obese than noncarriers (odds ration [OR] 19.5; 95%
confidence interval [CI], 2.4–146.8), suggesting a synergis-
tic effect between the two genes.
Gene–age interactions
The effects of genes may vary depending on a person’s
age. Argyropoulos et al (12) reported an association
between a mutation in the gene for agouti-related protein
(a strong appetite stimulator) and obesity in older adults.
The mutation was not associated with obesity in study sub-
jects with a mean age of 25 years but was significantly
associated with fat and abdominal adiposity in the sub-
jects’ parents, whose mean age was 53 years.
Gene–environment–lifestyle interactions
Numerous studies explored gene–environment–lifestyle
interactions. Martinez et al (13) found that an interaction
between diet and specific genes may affect obesity risk.
They found an increased obesity risk for women with a
Glu27 variant and a diet with more than 49% of calories
coming from carbohydrates. An alternate variant of that
same gene was not associated with an increased obesity
risk in relation to carbohydrate intake, given the same
number of calories consumed. Another study (14) found
that moderate alcohol intake was associated with reduced
abdominal fat among middle-aged women genetically pre-
disposed to obesity, whereas abstinence or light alcohol
intake was not. The study also found that among people
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genetic risk for obesity have lower levels of abdominal fat
than those with high genetic risk for obesity. This finding
suggests that the effect of diet on obesity depends on genet-
ic factors.
Changes in gene expression that result from epigenetic
influences (modifications of DNA structure rather than
DNA sequence) were also explored because of their poten-
tial role in obesity and associated chronic diseases.
Associations between fetal environment (undernutrition or
exposure to maternal hyperglycemia) and adult-onset obe-
sity may be due to epigenetic influences that promote fat
storage, but possible mechanisms are not well understood
(15,16).
Genes, obesity, and metabolic disorders
Distribution of fat, rather than amount of total body fat,
appears to play a key role in metabolic consequences asso-
ciated with obesity. Excess central abdominal fat is partic-
ularly associated with adverse consequences. People with
fat concentrated in the abdomen are more likely to develop
diabetes than are people with the same amount of fat dis-
tributed throughout the body (17). A study of post-
menopausal women also suggests that genetics has a role
in abdominal fat deposition (18).
Genomics in the Prevention and
Management of Obesity
Obesity prevention programs
Although many researchers and policy makers recognize
the need to mitigate the increasing rate of obesity, studies
indicate that the effectiveness of prevention strategies is
limited (19). Understanding the biology of weight regula-
tion, including the effect of an obesigenic environment on
gene expression, is essential to the development of effective
interventions. For instance, if obesity is related to genetic
changes caused by fetal exposures in utero or shortly after
birth, more emphasis on maternal and infant nutrition will
be needed.
As discussed earlier, children with obese parents are at
particular risk of becoming obese. Studies are needed to
determine the effectiveness of obesity screening and pre-
vention strategies based on family history. Also needed is
an evaluation of the effectiveness of identifying children at
risk for obesity at an early age (or even prenatally) and of
intervening with families to prevent those children from
gaining excess weight.
Nutrigenomics for weight management
The premise of nutrigenomics is that a person’s optimal
diet is determined by genetic makeup. Nutrigenomics
proponents maintain that dietary intervention based on
individual genotype can prevent or treat chronic disease
and manage weight (20). Although nutrigenomic profiling
combined with personalized interventions based on those
profiles may help prevent and manage obesity in the
future, data to support the efficacy of this approach are
not available now (21,22). Unfortunately, lack of data has
not stopped companies from marketing genetic tests
directly to the public and from making claims about the
efficacy of basing nutritional advice on the results of
those tests.
Pharmacogenomics in the management of obesity
Although development of drugs for obesity may have lit-
tle appeal for those who primarily advocate environmental
and lifestyle change, effective medications may be the best
hope for some individuals struggling to maintain a healthy
weight. Studies to identify the genomics of obesity and use
the results to develop drug treatments are under way (23).
Aitman (24) suggests that gene expression patterns may
help define particular subtypes of obesity and may help in
developing antiobesity drugs.
Environmental approaches
Although gene-based approaches (e.g., nutrigenomics,
pharmacogenomics) are not yet ready for widespread
application, information from genomic studies gives us
clues about how to manage obesity. In 2003, Lowe (25)
reported that people with a genetic predisposition to obe-
sity have difficulty self-regulating food intake to main-
tain weight loss or prevent weight gain, even if they had
extensive education in how to do so. Lowe concluded that
weight control programs that focus on lifestyle modifica-
tions based primarily on cognitive–behavioral change are
not effective because they do not consider that availabili-
ty of food is a biological stimulus to eating, particularly
for those genetically prone to obesity. Programs that pro-
vide portion-controlled, nutrient-dense meals may be
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more effective than other programs because they limit
opportunities for participants to consume energy-dense
foods. Lowe argues that, to stem the tide of obesity, indi-
viduals and communities need to eliminate many food
stimuli (e.g., overabundance of food, large portion sizes,
high-calorie foods).
Obesity and Future Public Health Practices
Genomics has the potential to improve the ability of pub-
lic health professionals to address the obesity epidemic.
However, additional work is needed to improve our under-
standing of the role of genes in obesity and to learn how to
use that understanding to prevent or manage the condi-
tion. Below are specific suggestions.
Surveillance and epidemiologic investigations
Baseline data are needed to understand familial risk
for obesity and to monitor changes in eating behavior.
Using family history information to estimate population
risk for obesity is a promising concept because family
history reflects genetic predisposition, behavioral fac-
tors, and shared environmental factors that may con-
tribute to obesity. Identifying population subgroups at
greater than average risk of obesity because of familial
factors may provide a basis for targeted intervention.
More data are also needed on the interactions between
genetic risks and environmental and lifestyle risks.
Valuable information could be gleaned by adding ques-
tions about family history of obesity to population sur-
veys (e.g., Behavioral Risk Factor Surveillance System)
and by cross-tabulating family history factors with
lifestyle and environmental factors.
Policy development
The advent of genetic technology introduced a new set of
public policy issues. Two such issues are genetic testing
and population databases.
Genetic testing
Direct-to-consumer marketing of genetic profiling raises
many questions about public policy: Should genetic testing
be regulated and by whom? Are there potential or real
harms to the public from not regulating genetic testing? In
the absence of regulation, should public health agencies
monitor genetic testing to ensure that public health is not
jeopardized?
Databases
Large-scale databases containing genetic information
could provide information about links between gene vari-
ants and health conditions such as obesity. Although the
potential benefits to various populations are great, the
associated risks for individuals with deleterious genetic
variants may also be great. The question is this: how do we
protect information in databases so as to prevent discrimi-
nation against individuals?
Ensuring access to health care
A key public health function is to ensure that everyone
has access to the services needed to achieve optimal
health. The potential for developing genetic tests with
results that can be used to decide which drugs are most
effective for treating obesity and other conditions holds
promise. Pharmacogenomics is already used to treat some
diseases (e.g., cancer). However, advances in pharmacoge-
nomics could also aggravate health disparities. As new
treatments emerge, public health will have an important
role in ensuring fair distribution of services to the entire
population (23,24).
Health education
Despite increasing exposure to genetic information
through the media and in schools, the public’s genetic lit-
eracy remains low. Misperceptions (e.g., genes equal des-
tiny) are common. Public health has an important role in
demystifying genetics and clarifying genetic concepts, not
only as they apply to obesity but also as they apply to other
health conditions. Studies to determine the value of incor-
porating genomic information into obesity prevention and
education programs are needed.
Professional development
Although health care and public health professionals are
working to increase their understanding of genomics,
many have limited knowledge of genomic concepts. To use
genomics effectively in developing and implementing obe-
sity interventions, public health professionals must
increase their understanding of the role of genes in health
and disease.
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Further research is needed to identify effective individ-
ual and population approaches to weight management
that incorporate genomic information, and large longitudi-
nal studies are needed to examine gene–environment–
lifestyle interactions on a population level (26,27). Such
studies must include both sexes, all races and ethnic
groups, and people of various ages. Well-executed studies
of prenatal subjects and public health populations (e.g.,
women enrolled in WIC, the U.S. Department of
Agriculture’s supplemental food program for women,
infants, and children) would contribute much to our under-
standing of genetic risk and its role in preventing or man-
aging obesity. Although scientists hope that personalized
health care based on genetic profiling will help people rec-
ognize their risk and improve their behavior, additional
evidence is needed to support this possibility.
Research Questions
Although the list of research questions is endless, sever-
al come immediately to mind: Can a family history of obe-
sity or genetic screening be used to identify high-risk fam-
ilies and target interventions to specific groups, particu-
larly children? What are the most effective ways of using
family history to screen for obesity? What are the most
effective intervention programs to prevent weight gain and
maintain healthy weight among children from obese fami-
lies? Does knowing they are at increased risk for obesity
(through family history or genetic testing) motivate people
to change behavior?
Conclusions
Obesity is almost always due to a combination of genet-
ic predisposition, lifestyle, and environment. Individual
variation in genes that influence eating behavior, satiety,
and taste are likely to affect the success of interventions,
which suggests that a one-size-fits-all approach may be
ineffective in preventing or treating obesity. In addition,
because of variations in genetic predisposition, the intensi-
ty of interventions required to prevent or treat obesity is
likely to vary among individuals. More research is needed
to effectively incorporate genomics into public health inter-
ventions for obesity.
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Table
Examples of Genes Involved in Obesity and Their Associated
Phenotypes
Leptin Satiation, metabolism
Melanocortin Feeding behavior, binge eating
Ghrelin Appetite stimulation




uncoupling proteins Energy expenditure
Melanocortin and MC4R Energy expenditure
For detailed information about single-gene mutations and their association
with obesity, see the Obesity Gene Map Database (9) and CDC’s Obesity
and Genetics: A Public Health Perspective (10).
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Gene Associated Phenotype (Characteristic)